Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Microbiota–Immune–Cognition Relationships from Neonatal Environments to Social Trajectories

Ziel

Being born preterm is the strongest known non-genetic factor for autism spectrum disorder (autism): risk is seven times higher, and up to eleven times higher with systemic inflammation. Despite this burden, Europe lacks predictive tools, validated therapeutic targets, and translational models to shift from late diagnosis to early intervention. MICRO-NEST addresses this gap through an integrated programme uniting expertise on the gut–microbiome–immune–brain axis with lived-experience co-creation.
The project will (1) identify and validate early predictive markers for clinical use, using world-first saliva glycomics and frozen-blood deep T-cell phenotyping; (2) discover and prioritise druggable therapeutic targets via AI pipelines and a patient-specific digital twin; (3) establish the first large-animal (sheep) model of prematurity-related autism with validated social-cognitive assessments; and (4) embed co-creation with autistic individuals, caregivers, clinicians, industry, and policymakers to ensure accessibility and policy relevance.
Human and preclinical findings will be harmonised across mouse, sheep, and nine established clinical cohorts, integrated with multimodal imaging, genetics, immune profiling, and microbiome data. AI-driven disease mapping and digital twin simulations will accelerate biomarker discovery, reduce animal use, and de-risk therapeutic design pipelines.
The impact will be transformative: earlier identification and preventive care for children with autism, stronger clinical decision support, reduced caregiver stress, and harmonised European guidelines. Industry will gain new diagnostics and therapeutic targets, SMEs valuable translational assets, and society reduced costs, greater inclusion, and recognition of neurodiversity. All outcomes will be shared under a unified FAIR & Reuse policy, positioning Europe as the global leader in autism innovation.

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-RIA - HORIZON Research and Innovation Actions

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-HLTH-2025-01

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Netto-EU-Beitrag
€ 952 612,50
Adresse
RUE DE TOLBIAC 101
75654 Paris
Frankreich
Region
Ile-de-France Ile-de-France Paris
Aktivitätstyp
Research Organisations
Links
Gesamtkosten
€ 952 612,50

Beteiligte (14)

Partner (1)